Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Wendra M. Foster"'
Autor:
Naga Chalasani, Thomas Hardy, Suman Duvvuru, Sudha S. Shankar, Anthony Akkari, Xiaotian Michelle Zhang, Sreekumar G. Pillai, Christof M. Kazda, Mark A. Deeg, Chakib Battioui, Pallav Bhatnagar, Wendra M. Foster, Cristina B. Guzman
Publikováno v:
Hepatology Communications. 2:561-570
LY2409021 is a glucagon receptor antagonist that was associated with hepatic steatosis and elevated aminotransferases in phase 2 diabetes studies. We investigated the relationship between selected genetic variants and hepatic steatosis and elevated a
Autor:
Edward J. Bastyr, Wendra M. Foster, Sreekumar G. Pillai, Axel Haupt, M Farmen, Byron J. Hoogwerf, C Harris, Suman Duvvuru, Sudha S. Shankar, Pallav Bhatnagar
Publikováno v:
The pharmacogenomics journal. 18(3)
Basal insulin peglispro (BIL) is a novel insulin with hepato-preferential action. In phase 3 trials, BIL showed significantly improved glycemic control but higher levels of transaminases (alanine aminotransferase (ALT) and aspartate aminotransferase
Autor:
Pallav Bhatnagar, Jeffrey S. Riesmeyer, Ellen McErlean, Kathy Wolski, Sreekumar G. Pillai, Stephen J. Nicholls, Giacomo Ruotolo, Wendra M. Foster, Govinda Weerakkody, A. Michael Lincoff, Steven E. Nissen, Lin Li
Publikováno v:
JAMA Cardiology. 3:401
Steven E. Nissen, Sreekumar G. Pillai, Stephen J. Nicholls, KathyWolski, Jeffrey S. Riesmeyer, Govinda J.Weerakkody, WendraM. Foster, Ellen McErlean, Lin Li, Pallav Bhatnagar, Giacomo Ruotolo, A. Michael Lincoff
Autor:
Lori E. Heath, Carolyn Hoppe, Bhatnagar Pallav, Wendra M. Foster, Joseph A. Jakubowski, Sreekumar G. Pillai
Publikováno v:
Blood. 130:962-962
Introduction: Sickle cell disease (SCD) is complex, with marked inter-individual variability in disease severity. The clinical heterogeneity of SCD is largely influenced by genetic factors, including several well-established modifiers of fetal hemogl